SFM
HARP

Sphera Funds Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Sphera Funds Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-38,403
Closed -$5.68M – 104
2019
Q4 		$5.68M Buy
38,403
+1,000
+3% +$152K 0.47% 48
2019
Q3 		$5.11M Hold
37,403
– – 0.79% 40
2019
Q2 		$4.86M Buy
37,403
+4,323
+13% +$502K 0.67% 43
2019
Q1 		$3.13M Buy
+33,080
New +$4.35M 0.29% 74

Other funds holding HARP

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sphera Funds Management's HARP Position: Q1 2020 in Review

Sphera Funds Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2020, closing a stake of 38,403 shares — an estimated $5.68M sold.

Sphera Funds Management first reported a position in HARP in Q1 2019 and held it in 4 quarters. The position peaked at $5.68M in Q4 2019. 53 funds tracked by Wall St. Rank hold HARP as of Q1 2020.

  • Sphera Funds Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Sphera Funds Management sold 38,403 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $5.68M.
  • Sphera Funds Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
  • Sphera Funds Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $5.68M in Q4 2019.
  • 53 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.